abstract |
Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with nucleic acid molecules encoding HBV surface antigens, HBV core antigens, and HBV polymerase antigens, and methods of administering same. The HBV RNAi agents and nucleic acid molecules are administered to effectively inhibit HBV gene expression and to treat HBV infections. |